Please login (Members) to view content or
(Nonmembers) this article.
No votes yet

Emerging Therapeutic Options for B-Cell Disorders: Idiopathic Thrombocytopenic Purpura and Chronic Lymphocytic Leukemia

Amy Goodrich
CJON 2007, 11(1), 23-36 DOI: 10.1188/07.CJON.S1.23-36

B-cell disorders include a large group of malignant and nonmalignant diseases with tremendous variation in incidence, natural history, treatment, and prognosis. This article will focus on adult idiopathic thrombocytopenic purpura (ITP) and chronic lymphocytic leukemia (CLL). Clinicians must individualize treatment for ITP and CLL to each patient. Observation without intervention is appropriate for some patients, whereas immediate treatment is indicated for others. Deciding when to treat and which agents to use can be difficult, but new therapeutic options are emerging for both conditions.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or